Henry J. Fuchs
2020
Compensation breakdown
Non-Equity Incentive Plan | $536,250 |
---|---|
Option Awards | $1,385,520 |
Salary | $769,231 |
Stock Awards | $4,732,826 |
Other | $32,748 |
Total | $7,456,575 |
Fuchs received $4.7M in stock awards, accounting for 63% of the total pay in 2020.
Fuchs also received $536.3K in non-equity incentive plan, $1.4M in option awards, $769.2K in salary and $32.7K in other compensation.
Rankings
In 2020, Henry J. Fuchs' compensation ranked 1,273rd out of 13,090 executives tracked by ExecPay. In other words, Fuchs earned more than 90.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,273 | 90th |
Manufacturing | 452 | 92nd |
Chemicals And Allied Products | 156 | 93rd |
Drugs | 135 | 93rd |
Pharmaceutical Preparations | 98 | 93rd |
Pay ratio
Henry J. Fuchs' Pay | $7,456,575 |
---|---|
Median Employee's Pay | $181,141 |
Pay Ratio | 41to 1 |
In 2020, the annual total compensation of Henry J. Fuchs was $7,456,575.
The annual total compensation of the median employee at BioMarin Pharmaceutical was $181,141.
The ratio of Henry J. Fuchs' pay to the pay of median employee was therefore 41 to one.
Fuchs' colleagues
We found six more compensation records of executives who worked with Henry J. Fuchs at BioMarin Pharmaceutical in 2020.
2020
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2020
C Guyer
BioMarin Pharmaceutical
Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations
2020
Brian Mueller
BioMarin Pharmaceutical
Chief Financial Officer
2020
Robert Baffi
BioMarin Pharmaceutical
Former President of Global Manufacturing and Technical Operations
2020
Jeff Ajer
BioMarin Pharmaceutical
Executive Vice President, Chief Commercial Officer
2020
Daniel Spiegelman
BioMarin Pharmaceutical
Chief Financial Officer
News
April 12, 2022
April 13, 2021
April 14, 2020
April 23, 2019